Apelin and its receptor APJ in cardiovascular diseases

被引：105

作者：

Yu, Xiao-Hua ^{[1
]}

Tang, Zhi-Bin ^{[3
]}

Liu, Li-Jing ^{[4
]}

Qian, Hong ^{[4
]}

Tang, Shi-Lin ^{[3
]}

Zhang, Da-Wei ^{[5
,6
]}

Tian, Guo-Ping ^{[7
]}

Tang, Chao-Ke ^{[1
,2
]}

机构：

[1] Univ South China, Life Sci Res Ctr, Hengyang 421001, Hunan, Peoples R China

[2] Univ South China, Inst Cardiovasc Res, Key Lab Atherosclerol Hunan Prov, Hengyang 421001, Hunan, Peoples R China

[3] Univ South China, Affiliated Hosp 1, Dept Orthoped, Hengyang 421001, Hunan, Peoples R China

[4] Huaihua Med Coll, Dept Clin Med, Huaihua 418000, Hunan, Peoples R China

[5] Univ Alberta, Dept Pediat, Edmonton, AB T6G 2S2, Canada

[6] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada

[7] Univ South China, Affiliated Hosp 2, Dept Cardiovasc Med, Hengyang 421001, Hunan, Peoples R China

来源：

CLINICA CHIMICA ACTA | 2014年 / 428卷

关键词：

Apelin; APJ; Atherosclerosis; CAD; Heart failure; Hypertension; ELEVATION MYOCARDIAL-INFARCTION; PERSISTENT ATRIAL-FIBRILLATION; EARLY CAROTID ATHEROSCLEROSIS; CHRONIC HEART-FAILURE; ENDOTHELIAL-CELLS; BLOOD-PRESSURE; REPERFUSION INJURY; PEPTIDE APELIN; IN-VIVO; CARDIAC CONTRACTILITY;

D O I：

10.1016/j.cca.2013.09.001

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Apelin is an adipokine that has been identified as an endogenous ligand for the orphan receptor APJ. Apelin and APJ are expressed in a diverse range of tissues with particular preponderance for the heart and vasculature. Apelin has powerful positive inotropic actions and causes endothelium- and nitric oxide-dependent vasodilatation. Growing evidence shows that apelin/APJ system functions as a critical mediator of cardiovascular homeostasis and is involved in the pathophysiology of cardiovascular diseases. Targeting apelin/APJ axis produces protection against cardiovascular diseases. In the current review we have summarized recent data concerning the role and therapeutic potential of apelin/APJ in several major cardiovascular diseases. An increased understanding of the cardiovascular actions of apelin/APJ system will help to develop novel therapeutic interventions for cardiovascular diseases. (C) 2013 Elsevier B.V. All rights reserved.

引用

页码：1 / 8

页数：8

共 98 条

[31] Requirement of apelin-apelin receptor system for oxidative stress-linked atherosclerosis [J].

Hashimoto, Tatsuo ;

Kihara, Minoru ;

Imai, Nozomi ;

Yoshida, Shin-Ichiro ;

Shimoyamada, Hiroaki ;

Yasuzaki, Hiroaki ;

Ishida, Junji ;

Toya, Yoshiyuki ;

Kiuchi, Yoshilhiro ;

Hirawa, Nobuhito ;

Tamura, Kouichi ;

Yazawa, Takuya ;

Kitamura, Hitoshi ;

Fukamizu, Akiyoshi ;

Umemura, Satoshi .

AMERICAN JOURNAL OF PATHOLOGY, 2007, 171 (05) :1705-1712

[32] Biomarkers in atrial fibrillation: a clinical review [J].

Hijazi, Ziad ;

Oldgren, Jonas ;

Siegbahn, Agneta ;

Granger, Christopher B. ;

Wallentin, Lars .

EUROPEAN HEART JOURNAL, 2013, 34 (20) :1475-+

[33] Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo [J].

Ishida, J ;

Hashimoto, T ;

Hashimoto, Y ;

Nishiwaki, S ;

Iguchi, T ;

Harada, S ;

Sugaya, T ;

Matsuzaki, H ;

Yamamoto, R ;

Shiota, N ;

Okunishi, H ;

Kihara, M ;

Umemura, S ;

Sugiyama, F ;

Yagami, K ;

Kasuya, Y ;

Mochizuki, N ;

Fukamizu, A .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (25) :26274-26279

[34] Identification and pharmacological properties of E339-3D6, the first nonpeptidic apelin receptor agonist [J].

Iturrioz, Xavier ;

Alvear-Perez, Rodrigo ;

De Mota, Nadia ;

Franchet, Christel ;

Guillier, Fabrice ;

Leroux, Vincent ;

Dabire, Hubert ;

Le Jouan, Melissande ;

Chabane, Hadjila ;

Gerbier, Romain ;

Bonnet, Dominique ;

Berdeaux, Alain ;

Maigret, Bernard ;

Galzi, Jean-Luc ;

Hibert, Marcel ;

Llorens-Cortes, Catherine .

FASEB JOURNAL, 2010, 24 (05) :1506-1517

[35] Down-regulation of cardiac apelin system in hypertrophied and failing hearts: Possible role of angiotensin II-anglotensin type 1 receptor system [J].

Iwanaga, Yoshitaka ;

Kihara, Yasuki ;

Takenaka, Hiroyuki ;

Kita, Toru .

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2006, 41 (05) :798-806

[36] Acute Cardiovascular Effects of Apelin in Humans Potential Role in Patients With Chronic Heart Failure [J].

Japp, A. G. ;

Cruden, N. L. ;

Barnes, G. ;

van Gemeren, N. ;

Mathews, J. ;

Adamson, J. ;

Johnston, N. R. ;

Denvir, M. A. ;

Megson, I. L. ;

Flapan, A. D. ;

Newby, D. E. .

CIRCULATION, 2010, 121 (16) :1818-U56

[37] Apeliin activates L-arginine/nitric oxide synthase/nitric oxide pathway in rat aortas [J].

Iia, Yue Xia ;

Lu, Zheng Fei ;

Zhang, Jing ;

Pan, Chun Shui ;

Yang, Jing Hui ;

Zhao, Jing ;

Yu, Fang ;

Duan, Xiao Hui ;

Tang, Chao Shu ;

Qi, Yong Fen .

PEPTIDES, 2007, 28 (10) :2023-2029

[38] Cardiovascular effects of a PEGylated apelin [J].

Jia, Z. Q. ;

Hou, L. ;

Leger, A. ;

Wu, I. ;

Kudej, A. B. ;

Stefano, J. ;

Jiang, C. ;

Pan, C. Q. ;

Akita, G. Y. .

PEPTIDES, 2012, 38 (01) :181-188

[39] Interactive Association of Five Candidate Polymorphisms in Apelin/APJ Pathway with Coronary Artery Disease among Chinese Hypertensive Patients [J].

Jin, Wei ;

Su, Xiuxiu ;

Xu, Min ;

Liu, Yan ;

Shi, Jingyi ;

Lu, Lin ;

Niu, Wenquan .

PLOS ONE, 2012, 7 (12)

[40] The differential anti-inflammatory effects of exercise modalities and their association with early carotid atherosclerosis progression in patients with Type 2 diabetes [J].

Kadoglou, N. P. E. ;

Fotiadis, G. ;

Kapelouzou, A. ;

Kostakis, A. ;

Liapis, C. D. ;

Vrabas, I. S. .

DIABETIC MEDICINE, 2013, 30 (02) :E41-E50

← 1 2 3 4 5 6 7 8 9 10 →